Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. (2016)
Attributed to:
MICA: Exploring GABAAalpha2,3 receptor signalling as novel therapy for focal dystonias and peripheral neuropathies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(16)00004-1
PubMed Identifier: 26822749
Publication URI: http://europepmc.org/abstract/MED/26822749
Type: Journal Article/Review
Volume: 15
Parent Publication: The Lancet. Neurology
Issue: 3
ISSN: 1474-4422